FDA Approves Extended-Release Injection for Opioid Use Disorder
Lori Solomon
TUESDAY, May 30, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has approved Brixadi (buprenorphine)…
Browsing Tag
ExtendedRelease
Avadel Pharmaceuticals Announces Final FDA Approval of LUMRYZ™ (sodium oxybate) for…
<!-- Name:DistributionId Value:8829171 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Less Abuse With Extended-Release Oxycodone, Poison Center Data Suggest
FORT LAUDERDALE, Fla. -- An abuse-deterrent formulation of oxycodone led to fewer severe medical outcomes and less intentional…
Extended-Release Risperidone Injectable Staves Off Schizophrenia Relapse
An investigational long-acting antipsychotic containing risperidone, known as TV-46000, was able to significantly delay time to…